BioIntelliSense
BioIntelliSense is a medical technology company that provides continuous medical grade monitoring solutions, including the BioButton device for vital sign monitoring and the BioCloud analytics platform.
Medical Grade Remote Care Solutions
BioIntelliSense offers medical grade remote care solutions designed to provide continuous monitoring from in-hospital settings to home care environments. This range of services includes advanced monitoring technologies and analytics tools aimed at improving patient outcomes through continuous and accurate tracking of vital signs.
BioButton Wearable Device
BioIntelliSense provides the BioButton, a multi-parameter wearable device that enables continuous vital sign monitoring. The BioButton is designed for use in various care settings, offering a streamlined solution for tracking patient health metrics such as temperature, respiratory rate, and heart rate. This device supports both clinical and at-home monitoring.
Acquisition of AlertWatch Clinical Intelligence Engine
BioIntelliSense has expanded its patient monitoring solutions through the acquisition of the AlertWatch clinical intelligence engine. This acquisition aims to enhance the company's capabilities in providing comprehensive patient monitoring by integrating AlertWatch’s advanced analytical tools for better clinical insights and decision making.
Partnership with Medtronic
BioIntelliSense formed a strategic partnership with Medtronic to distribute BioButton medical grade wearables in U.S. hospitals. This collaboration aims to broaden the reach of BioIntelliSense’s innovative monitoring solutions, providing healthcare providers with robust tools for continuous patient care.
BioCloud Data Analytics Platform
BioIntelliSense utilizes BioCloud, a data analytics platform designed for high-frequency vital sign trending and reporting. BioCloud enables healthcare providers to access detailed and timely insights into patient health, facilitating proactive and informed clinical decisions.
BioDashboard for Clinical Decision Support
BioIntelliSense offers BioDashboard, an intuitive platform for exception-based management and clinical decision support. The BioDashboard helps healthcare professionals manage patient data more effectively, focusing on critical anomalies and providing actionable insights that support improved patient care.
Pulse Oximetry (SpO2) Sensor Technology
BioIntelliSense has launched a patented, FDA-cleared Pulse Oximetry (SpO2) sensor technology. This innovation addresses common challenges in skin pigmentation and motion monitoring, ensuring more accurate and reliable measurements of blood oxygen levels during continuous monitoring.
Series B Financing Round
BioIntelliSense closed an oversubscribed $45M Series B financing round with the goal of scaling its Data-as-a-Service and clinical intelligence platform. This funding round is intended to support the expansion of their continuous monitoring solutions and enhance their clinical intelligence capabilities.